Jim Pomeroy

Vice President, Quality and Regulatory Affairs

Jim joined Regenity in May 2026. He brings more than 25 years of leadership experience across FDA-regulated medical device organizations, with deep expertise spanning operations, research and development, and global regulatory, quality, and clinical functions. Most recently, he served as Senior Vice President, Global Quality, Regulatory Affairs, and Clinical Affairs at a leading global orthopedic device company, where he was responsible for enterprise-wide compliance, product lifecycle quality, and clinical strategy across a complex, multi-region organization.

Throughout his career, Jim has demonstrated a strong track record of driving operational excellence and strengthening quality and regulatory systems in highly regulated environments. He has led global organizations through significant regulatory change, including implementation of EU MDR, while maintaining strong compliance and enabling business growth. Jim’s experience includes leading regulatory strategy, overseeing clinical evidence generation, and ensuring robust quality systems that support both innovation and commercialization.

Education:

Jim holds a Bachelor of Science degree in Electrical and Computer Engineering from Valparaiso University.

Quote

It’s great to be part of a company that is focused on making a positive difference in patient lives and doing it with the right core values. Regenity has a relentless pursuit to deliver the highest quality products and services to our customers, while maintaining a culture that puts the patient first.

Jim Pomeroy Vice President, Quality and Regulatory Affairs

Leadership Team

Read More

Aaron Kendrick

Senior Vice President Operations
Read More

Susan Miller

Head of Human Resources
Read More

Jessica Swanson

Vice President of Marketing
Read More

Bill Messer

Vice President of Commercial Operations
Read More

Tim Starr

Chief Operating Officer
Read More

Peggy Hansen

General Manager, Contract Development + Manufacturing & Senior Vice President, Regulatory, Quality and Clinical Affairs
Read More

Oystein Valberg

Chief Financial Officer
Read More

Shawn McCarthy

Chief Executive Officer